Report Detail

Request for Sample of this report

Chemical & Material Global Medical Biomedical Materials 3.0 Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4643225
    • |
  • 24 October, 2025
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Medical Biomedical Materials 3.0 market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
The third generation of biological materials: the biological active materials and biodegradable materials, to combine these two independent concepts in modification of biodegradable materials, combined with cell integrin, induction of cell proliferation, differentiation, and the synthesis of extracellular matrix and assembly, so as to start the regeneration system of the body, belong to the category of regenerative medicine.The third generation of biomaterials is represented by tissue engineering scaffold materials, in-situ tissue regeneration materials, degradable composite cells and/or growth factor materials.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Medical Biomedical Materials 3.0 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Biomedical Materials 3.0 market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Medical Biomedical Materials 3.0 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Medical Biomedical Materials 3.0 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Medical Biomedical Materials 3.0 market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Biomedical Materials 3.0
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Biomedical Materials 3.0 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, PCAS, Fujifilm, Evonik Health Care, Nomisma Healthcare, Corbion, DURECT, Mitsui Chemicals, Phosphorex Inc., Lattice Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Biomedical Materials 3.0 market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PLA
PGA
PLGA
PLCG
Other
Market segment by Application
Suture
Fracture Fixation
Oral Implant
Drug Delivery Microsphere
Others
Major players covered
Merck
PCAS
Fujifilm
Evonik Health Care
Nomisma Healthcare
Corbion
DURECT
Mitsui Chemicals
Phosphorex Inc.
Lattice Medical
Jinan Daigang Biomaterial
Shenzhen Polymtek Biomaterial Co., Ltd.
Changchun Foliaplast Bio-tech Co., Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Biomedical Materials 3.0 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Biomedical Materials 3.0, with price, sales quantity, revenue, and global market share of Medical Biomedical Materials 3.0 from 2020 to 2025.
Chapter 3, the Medical Biomedical Materials 3.0 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Biomedical Materials 3.0 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medical Biomedical Materials 3.0 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Biomedical Materials 3.0.
Chapter 14 and 15, to describe Medical Biomedical Materials 3.0 sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Biomedical Materials 3.0 Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 PLA
    • 1.3.3 PGA
    • 1.3.4 PLGA
    • 1.3.5 PLCG
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Biomedical Materials 3.0 Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Suture
    • 1.4.3 Fracture Fixation
    • 1.4.4 Oral Implant
    • 1.4.5 Drug Delivery Microsphere
    • 1.4.6 Others
  • 1.5 Global Medical Biomedical Materials 3.0 Market Size & Forecast
    • 1.5.1 Global Medical Biomedical Materials 3.0 Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Medical Biomedical Materials 3.0 Sales Quantity (2020-2031)
    • 1.5.3 Global Medical Biomedical Materials 3.0 Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Medical Biomedical Materials 3.0 Product and Services
    • 2.1.4 Merck Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 PCAS
    • 2.2.1 PCAS Details
    • 2.2.2 PCAS Major Business
    • 2.2.3 PCAS Medical Biomedical Materials 3.0 Product and Services
    • 2.2.4 PCAS Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 PCAS Recent Developments/Updates
  • 2.3 Fujifilm
    • 2.3.1 Fujifilm Details
    • 2.3.2 Fujifilm Major Business
    • 2.3.3 Fujifilm Medical Biomedical Materials 3.0 Product and Services
    • 2.3.4 Fujifilm Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Fujifilm Recent Developments/Updates
  • 2.4 Evonik Health Care
    • 2.4.1 Evonik Health Care Details
    • 2.4.2 Evonik Health Care Major Business
    • 2.4.3 Evonik Health Care Medical Biomedical Materials 3.0 Product and Services
    • 2.4.4 Evonik Health Care Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Evonik Health Care Recent Developments/Updates
  • 2.5 Nomisma Healthcare
    • 2.5.1 Nomisma Healthcare Details
    • 2.5.2 Nomisma Healthcare Major Business
    • 2.5.3 Nomisma Healthcare Medical Biomedical Materials 3.0 Product and Services
    • 2.5.4 Nomisma Healthcare Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Nomisma Healthcare Recent Developments/Updates
  • 2.6 Corbion
    • 2.6.1 Corbion Details
    • 2.6.2 Corbion Major Business
    • 2.6.3 Corbion Medical Biomedical Materials 3.0 Product and Services
    • 2.6.4 Corbion Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Corbion Recent Developments/Updates
  • 2.7 DURECT
    • 2.7.1 DURECT Details
    • 2.7.2 DURECT Major Business
    • 2.7.3 DURECT Medical Biomedical Materials 3.0 Product and Services
    • 2.7.4 DURECT Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 DURECT Recent Developments/Updates
  • 2.8 Mitsui Chemicals
    • 2.8.1 Mitsui Chemicals Details
    • 2.8.2 Mitsui Chemicals Major Business
    • 2.8.3 Mitsui Chemicals Medical Biomedical Materials 3.0 Product and Services
    • 2.8.4 Mitsui Chemicals Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Mitsui Chemicals Recent Developments/Updates
  • 2.9 Phosphorex Inc.
    • 2.9.1 Phosphorex Inc. Details
    • 2.9.2 Phosphorex Inc. Major Business
    • 2.9.3 Phosphorex Inc. Medical Biomedical Materials 3.0 Product and Services
    • 2.9.4 Phosphorex Inc. Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Phosphorex Inc. Recent Developments/Updates
  • 2.10 Lattice Medical
    • 2.10.1 Lattice Medical Details
    • 2.10.2 Lattice Medical Major Business
    • 2.10.3 Lattice Medical Medical Biomedical Materials 3.0 Product and Services
    • 2.10.4 Lattice Medical Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Lattice Medical Recent Developments/Updates
  • 2.11 Jinan Daigang Biomaterial
    • 2.11.1 Jinan Daigang Biomaterial Details
    • 2.11.2 Jinan Daigang Biomaterial Major Business
    • 2.11.3 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Product and Services
    • 2.11.4 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Jinan Daigang Biomaterial Recent Developments/Updates
  • 2.12 Shenzhen Polymtek Biomaterial Co., Ltd.
    • 2.12.1 Shenzhen Polymtek Biomaterial Co., Ltd. Details
    • 2.12.2 Shenzhen Polymtek Biomaterial Co., Ltd. Major Business
    • 2.12.3 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Product and Services
    • 2.12.4 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Shenzhen Polymtek Biomaterial Co., Ltd. Recent Developments/Updates
  • 2.13 Changchun Foliaplast Bio-tech Co., Ltd
    • 2.13.1 Changchun Foliaplast Bio-tech Co., Ltd Details
    • 2.13.2 Changchun Foliaplast Bio-tech Co., Ltd Major Business
    • 2.13.3 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Product and Services
    • 2.13.4 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Changchun Foliaplast Bio-tech Co., Ltd Recent Developments/Updates

3 Competitive Environment: Medical Biomedical Materials 3.0 by Manufacturer

  • 3.1 Global Medical Biomedical Materials 3.0 Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Medical Biomedical Materials 3.0 Revenue by Manufacturer (2020-2025)
  • 3.3 Global Medical Biomedical Materials 3.0 Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Medical Biomedical Materials 3.0 by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Medical Biomedical Materials 3.0 Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Medical Biomedical Materials 3.0 Manufacturer Market Share in 2024
  • 3.5 Medical Biomedical Materials 3.0 Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Biomedical Materials 3.0 Market: Region Footprint
    • 3.5.2 Medical Biomedical Materials 3.0 Market: Company Product Type Footprint
    • 3.5.3 Medical Biomedical Materials 3.0 Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Biomedical Materials 3.0 Market Size by Region
    • 4.1.1 Global Medical Biomedical Materials 3.0 Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Medical Biomedical Materials 3.0 Consumption Value by Region (2020-2031)
    • 4.1.3 Global Medical Biomedical Materials 3.0 Average Price by Region (2020-2031)
  • 4.2 North America Medical Biomedical Materials 3.0 Consumption Value (2020-2031)
  • 4.3 Europe Medical Biomedical Materials 3.0 Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Medical Biomedical Materials 3.0 Consumption Value (2020-2031)
  • 4.5 South America Medical Biomedical Materials 3.0 Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Medical Biomedical Materials 3.0 Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Medical Biomedical Materials 3.0 Sales Quantity by Type (2020-2031)
  • 5.2 Global Medical Biomedical Materials 3.0 Consumption Value by Type (2020-2031)
  • 5.3 Global Medical Biomedical Materials 3.0 Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Medical Biomedical Materials 3.0 Sales Quantity by Application (2020-2031)
  • 6.2 Global Medical Biomedical Materials 3.0 Consumption Value by Application (2020-2031)
  • 6.3 Global Medical Biomedical Materials 3.0 Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Medical Biomedical Materials 3.0 Sales Quantity by Type (2020-2031)
  • 7.2 North America Medical Biomedical Materials 3.0 Sales Quantity by Application (2020-2031)
  • 7.3 North America Medical Biomedical Materials 3.0 Market Size by Country
    • 7.3.1 North America Medical Biomedical Materials 3.0 Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Medical Biomedical Materials 3.0 Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Medical Biomedical Materials 3.0 Sales Quantity by Type (2020-2031)
  • 8.2 Europe Medical Biomedical Materials 3.0 Sales Quantity by Application (2020-2031)
  • 8.3 Europe Medical Biomedical Materials 3.0 Market Size by Country
    • 8.3.1 Europe Medical Biomedical Materials 3.0 Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Medical Biomedical Materials 3.0 Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Biomedical Materials 3.0 Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Medical Biomedical Materials 3.0 Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Medical Biomedical Materials 3.0 Market Size by Region
    • 9.3.1 Asia-Pacific Medical Biomedical Materials 3.0 Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Medical Biomedical Materials 3.0 Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Medical Biomedical Materials 3.0 Sales Quantity by Type (2020-2031)
  • 10.2 South America Medical Biomedical Materials 3.0 Sales Quantity by Application (2020-2031)
  • 10.3 South America Medical Biomedical Materials 3.0 Market Size by Country
    • 10.3.1 South America Medical Biomedical Materials 3.0 Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Medical Biomedical Materials 3.0 Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Medical Biomedical Materials 3.0 Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Medical Biomedical Materials 3.0 Market Size by Country
    • 11.3.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Medical Biomedical Materials 3.0 Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Medical Biomedical Materials 3.0 Market Drivers
  • 12.2 Medical Biomedical Materials 3.0 Market Restraints
  • 12.3 Medical Biomedical Materials 3.0 Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Biomedical Materials 3.0 and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Biomedical Materials 3.0
  • 13.3 Medical Biomedical Materials 3.0 Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Biomedical Materials 3.0 Typical Distributors
  • 14.3 Medical Biomedical Materials 3.0 Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Biomedical Materials 3.0. Industry analysis & Market Report on Medical Biomedical Materials 3.0 is a syndicated market report, published as Global Medical Biomedical Materials 3.0 Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Medical Biomedical Materials 3.0 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo